logo
Book a meeting
Vapogenix

Vapogenix

Pharmaceuticals, 8285 El Rio St Ste 150, Houston, Texas, 77054, United States, 1-10 Employees

vapogenix.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 71********

Who is VAPOGENIX

Vapogenix is a clinical stage company developing a new class of non-narcotic analgesics for localized pain. While most pain is localized, most pain medications are administered orally (sy...

Read More

lock icon Get Full Access
map
  • 8285 El Rio St Ste 150, Houston, Texas, 77054, United States Headquarters: 8285 El Rio St Ste 150, Houston, Texas, 77054, United States
  • 2006 Date Founded: 2006
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834 | NAICS Code: 999990 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from VAPOGENIX

Vapogenix Org Chart and Mapping

Employees
Ajay Rege

Ajay Rege

Director of Drug Development

See Full Org Chart arrow
email-formate-icon
View Email Formats for Vapogenix
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Vapogenix

Answer: Vapogenix's headquarters are located at 8285 El Rio St Ste 150, Houston, Texas, 77054, United States

Answer: Vapogenix's phone number is 71********

Answer: Vapogenix's official website is https://vapogenix.com

Answer: Vapogenix's revenue is $1 Million to $5 Million

Answer: Vapogenix's SIC: 2834

Answer: Vapogenix's NAICS: 999990

Answer: Vapogenix has 1-10 employees

Answer: Vapogenix is in Pharmaceuticals

Answer: Vapogenix contact info: Phone number: 71******** Website: https://vapogenix.com

Answer: Vapogenix is a clinical stage company developing a new class of non-narcotic analgesics for localized pain. While most pain is localized, most pain medications are administered orally (systemically), resulting in side effects. We are focused on treating pain locally at its source. Our products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. Our first product, which recently completed its first clinical trial, is a rapidly acting topical analgesic to alleviate pain associated with venipuncture, venous cannulation and minor dermatological procedures. Our next products will focus on treating wound pain and localized inflammatory pain.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access